ABSTRACT Primary (AL) amyloidosis is a plasma cell dyscrasia characterized by extracellular deposition of monoclonal light chain variable region (V) fragments in the form of amyloid fibrils. Light-chain amyloid is rare, and it is not fully understood why it occurs in only a fraction of patients with a circulating monoclonal component and why it typically associates with isotype and VI familylight chain proteins. To provide insights into these issues, we obtained complete nucleotide sequences of monoclonal V regions from 55 consecutive unselected cases of primary amyloidosis and the results were compared with the light chain expression profile of polyclonal marrow plasma cells from 3 normal donors (a total of 264 sequences). We demonstrated that: a) the III family is the most frequently employed both in amyloidosis (47%) and in polyclonality (43%); b) both conditions are characterized by gene restriction; c) a very skewed repertoire is a feature of amyloidosis, since just two germline genes belonging to the III and VI families, namely 3r (22% of cases, III) and 6a (20%, VI), contributed equally to encode 42% of amyloid V regions; d) these same two gene segments have a strong association with amyloidosis if their prevalences are compared with those in polyclonal conditions (3r, 8.3%, P=.024; 6a, 2.3%, P=.0008, 2 test); e) the J 2/3 segment, encoding the 4 th framework region, appears to be slightly overrepresented in AL (83% vs 67%, P=.03), and this might be related to preferential J 2/3 rearrangement in amyloid (11/12 cases) vs polyclonal 3r-light chains (13/22 cases). These findings demonstrate that V -J
INTRODUCTION
Immunoglobulin light chain-related (AL) amyloidosis is the most common form of amyloidosis in Western countries and the only one caused by a tumor. A marrow plasma cell clone (1) synthesizes structurally unstable monoclonal light chains whose variable (V) domains form systemic amyloid deposits (2) . In most cases AL amyloidosis leads to organ failure and finally death (3, 4) .
Only a few Bence Jones proteins form amyloid in vivo and light chains are observed approximately two times more frequently than ones (2, 5) . These observations suggest the existence of V genes with a propensity to form amyloid (amyloidogenic). Indeed, light chain protein sequencing (6) and ELISA typing (7) showed a very high prevalence of VI family light chains in amyloidosis and a strong association with this disorder: with rare exceptions, VI monoclonal light chains are found only in patients with AL. Since this seminal observation, no other amyloid-associated genes have been identified.
Virtually any organ excluding the brain parenchyma can be the target of amyloid systemic deposition, and in almost any combination. The reasons for the diversity in organ distribution of AL amyloidosis are unknown. Very recently, Comenzo et al (8) documented that VI light chains were more likely to be found in patients with dominant renal involvement at diagnosis, raising the possibility that, at least in some instances, the diverse organ tropism of amyloid light chains may be influenced by VL gene usage.
To provide insights into the above issues, we report here the first comparative V germline gene usage analysis in plasma cells from amyloidosis and normal polyclonal bone marrow and analyze the relationship between amyloid V expression and specific organ damage.
MATERIALS AND METHODS

Patient population, clinical data and materials
The patient population consisted of 55 consecutive amyloid cases enrolled at the coordinating center of the Italian Amyloid Program (Internal Medicine and Medical Oncology, University of Pavia, Pavia, Italy). All patients had biopsy-proven amyloidosis (apple-green birefringence of Congo red-stained specimens) in one or more sites. Abdominal fat aspiration was performed in all patients (85% positive), and a biopsy was taken from the clinically dominant organ in 25 cases (45%, all positive, often performed in other institutions), and from other typical sites (i.e. rectum, gingiva, labial salivary glands) in 6 cases (11%, all positive). Patients were categorized
For personal use only. on October 19, 2017 . by guest www.bloodjournal.org From for the dominant syndrome at presentation according to the major clinical manifestations and laboratory data, including ultrasound studies (9, 10) . In the case of multiple organ involvement, patients were assigned according to the most prominent characteristic. For instance, a patient with nephrotic syndrome and congestive heart failure, with characteristic echocardiograph changes, was assigned to the heart group, while a patient with clinically overt nephrotic syndrome and asymptomatic heart involvement (with minor echocardiograph changes only, i.e. interventricular septum thickness of 12 mm) was assigned to the kidney group. Renal involvement was defined as 24h proteinuria >0.5 g and/or serum creatinine > 1.2 mg/dL, or renal failure and dialysis. The following echocardiograph features defined heart involvement: mean interventricular wall thickness 13 mm (or 12 mm in case of typical granular sparkling or diastolic dysfunction, 14 mm in presence of arterial hypertension). Patients were stratified according to the New York Heart Association (NYHA) classification and those defined as having dominant cardiac involvement were in class 2. Liver involvement was defined as hepatomegaly (at ultrasound) and an increase of serum alkaline phosphatase level more than 279 U/L (institutional upper reference limit), with ALT and AST below double the upper reference limit. Neuropathic involvement was defined based on clinical history, paresthesias, orthostatic hypotension, delayed emptying at gastric scans, diarrhea or persistent constipation, abnormal EMG, impotence, absence of intra-day variations of heart frequency at Holter ECG. Patients with unobvious involvement, such as GI or urinary tract, lung, soft tissue or lymph node involvement, underwent organ biopsies to confirm amyloid.
Association with clinically overt multiple myeloma was excluded by the absence of osteolytic lesions or generalized osteoporosis, hypercalcemia, anemia and BMPC 20%.
A bone marrow aspirate was taken at diagnosis after obtaining the patients' informed consent.
Bone marrow plasma cells from three donors were used as controls for V gene usage in the normal population. The donors had no history of chronic infection and were apparently in good health.
Cloning and sequencing of immunoglobulin light chain variable regions
The V regions were isolated by an inverse polymerase chain reaction (PCR)-based procedure previously described in detail (11) . Briefly, double-stranded cDNA from Ficoll-separated bone marrow mononuclear cells was blunt-ended, ligated upon itself to form a circle using T4 DNA ligase (GIBCO-BRL, Grand Island, NY), PCR-amplified with primers specific for the 5' and 3' ends of the light chain constant region and oriented toward the V region (5' primer) or toward the 3' end of the constant region (3' primer). The PCR products were gel-purified and plasmid cloned.
Several plasmid inserts were then sequenced on either strand using an automated DNA sequencer and compared to each other. Since primers (both placed on the constant region) cannot generate For personal use only. on October 19, 2017 . by guest www.bloodjournal.org From amplification bias, the presence of the same V region sequence in multiple clones indicates its monoclonal origin. That the monoclonal V region did indeed correspond to the amyloidogenic light chain was demonstrated by partial amino acid sequencing from the deposited light chain (12) .
Conversely, in the case of normal bone marrow, cloned V sequences differed from each other, as expected for a polyclonal condition.
In the case of amyloid light chains, multiple inserts (median 5, range 3-12) from each cloning procedure were sequenced for a total of 284 plasmid clones. In every case (100% efficiency) it was possible to identify a single, identical, repeated V region that was considered monoclonal. In 29 patients (53%), all sequenced inserts contained just the same monoclonal V region fragment. In other cases, different V sequences were observed together with the predominant monoclonal ones, an occurrence that had been previously noted and attributed to residual polyclonal plasma cells (12) .
Monoclonal amyloid sequences were derived from analysis of an average of 4 (range 3-9) repeated plasmid clones. Even when several repeated clones were analyzed from the same patient (7 cases, 6 inserts; 1 case, 7 inserts; 1 case, 8 inserts; 1 case, 9 inserts), no significant nucleotide substitution was observed. Nucleotide sequences of the V regions were submitted to the GenBank database † .
Since there is no information on the expression repertoire of V genes in polyclonal marrow plasma cells, inverse-PCR was employed to characterize V regions from 3 normal donors. A total of 264 diverse sequences were analyzed and were all potentially functional. In normal donors, the inverse-PCR was run using total RNA extracted from plasma cells isolated via CD138 (syndecan-1) indirect immunomagnetic selection (Dynal, Oslo, Norway). RNA from unselected bone marrow mononuclear cells was used in the case of amyloid patients.
Identification of V and J germline segments
In order to identify the presumed germline genes of V regions, alignment was made with the current releases of EMBL-GenBank and V-BASE (V BASE Sequence Directory, Tomlinson et al, MRC Centre for Protein Engineering, Cambridge, UK) sequence directories using the BLAST (13) and DNAPLOT (Althaus H-H, University of Cologne, Germany) search tools, respectively.
Sequences were all potentially functional (no stop codons, frameshifts, or pseudogenes).
Statistical analysis
Means and standard deviations were used to describe continuous variables, absolute and relative frequencies to describe categorical variables. Confidence intervals (at 95% level) were † accession numbers: AF 462643-AF462689, AF026919-AF026926 Station, TX) was used for all computations.
RESULTS
Patient population
The patients'characteristics are listed in (14) . The most frequently observed dominant syndromes at diagnosis involved the kidney and heart (together they accounted for 71% of all organs). Figure 6 . Abbreviations: MP, mephalan and prednisone; M-HDex, melphalan plus high-dose dexamethasone; HDex, high-dose dexamethasone; HDCT, high -dose chemotherapy; ASCI, autologous stem cell transplant; Iodo-DOX, 4'-Iodo-4'-deoxydoxorubicin.
Family and germline gene usage in amyloid and polyclonal light chains
Amyloid (#55) and polyclonal (#264) sequences were tested in databases to identify the best matching V and J germline segments. Unequivocal assignment was possible in all cases. V family ( Figure 1 ) and germline gene uses (data not shown) were found to be quite similar in the 3 normal donors (widely overlapping confidence intervals), and results were pooled. followed by 2a2 ( II, 12%), 1e ( I), 3m ( III) and 3r ( III), each found in 8% of sequences. The rearrangement frequencies of the above germline genes were significantly higher than predicted from their presence in the genome (P<.001). Some segments were rarely observed while others (2d,3e,4a,4c,5e,5c,7b) were never found.
Biased expression was even more evident in amyloidosis since only 3 gene segments were sufficient to encode 53% of V regions (in decreasing order of magnitude, 3r,6a,3h). The rearrangement frequencies of 3r (22%) and 6a (20%) were much higher than in polyclonality, revealing a preferential association of these genes with amyloidosis (3r, P=.024; 6a, P=.0008, significance lessened according to Bonferroni). Germline segment 3h, the one most frequently involved in polyclonal light chains (15%), was rearranged to a similar degree in AL (11%). segment is the most frequently used in both conditions; however, usage of this segment appears to be higher in amyloidosis as compared to in polyclonality (P=.030); conversely, the J 1 segment is less frequently involved in AL (P=.016).
Somatic mutations were found in all sequences, and the overall frequency of nucleotide substitution was lower in amyloidosis than in polyclonality (amyloid, mean 6.4%, 95% CI, 5.7-7.2%; polyclonality, mean 7.4%, 95% CI, 7.0-7.8%, P=.021). Figure 5 reports the mutation rates of individual V families for the two conditions. In amyloidosis, the III-family, and its subset of 3r-light chains, were significantly less homologous to germline than VI/6a-light chains (P=.019 and
P=.018, respectively).
For Overall, the frequency of somatic changes is significantly higher in polyclonal than in amyloid light chains. In amyloidosis, the III light chains are more mutated than the VI (6a)-light chains (*P=.019). This holds true also for 3r-light chains vs 6a-light chains (°P=.018). Germline gene 6a is the single germline gene of the VI family. P, polyclonal; A, amyloidosis.
Germline gene usage in amyloid light chains and the dominant organ syndrome
The distributions of the dominant organ syndromes at diagnosis in the 55 consecutive patients and in the 3r-and 6a-light-chain cases are reported in Figure 6 . The distribution observed in the 3r-patients paralleled that in the general patient population (Figure 6 ). By contrast, kidney involvement was overrepresented in the 6a-patients (P=.019). There was no difference in the numbers of organs involved at diagnosis between patients with 3r-and 6a-light chains (P=.207). Figure 6 . V germline gene usage and major amyloid organ involvement at diagnosis. The distributions of the major organ involved are reported for the general population and for the 3r-and 6a-light chain patients. 6a-light chains are more frequently observed in patients with major kidney amyloid (P=.019), whereas 3r-light chains appear to be able to infiltrate all amyloid organ targets.
Heart
DISCUSSION
This study reports the first expression repertoire analyses of V -J segments in plasma cells from amyloidosis and normal bone marrow. Useful information is derived for light chain genetics in both conditions. Lambda amyloid gene usage is highly restricted in both conditions, amyloid and normal, with significant overexpression of two germline genes, 3r and 6a, and, possibly, of the J 2/3 segment in amyloidosis.
Repertoire analyses in pathological conditions must satisfy some fundamental features; these include an unbiased and efficient sequencing strategy, an unselected patient population, and information on the normal repertoire in order to test the significance of findings.
Sequencing data were obtained by means of an established inverse-PCR sequencing strategy (11); since both primers are located on the constant region, all V regions can be efficiently members of the III family (3h, 15%; 3m and 3r, 8% each), a II-(2a2, 12%) and a I member (1e, 8%). The most frequently used gene segment was the III family member 3h, which was found to be rearranged at a remarkably similar frequency (11.9%; 14.6%; 13.8%). With the exception of 1e, the other 4 dominating segments are less than 200 kb close to the J -C cluster and belong to For personal use only. on October 19, 2017 . by guest www.bloodjournal.org From cluster A, which contains the II and III families and one member of the IV family (24) . The polyclonal expressed repertoire is therefore restricted, due to bias in the rearrangement of a few germline genes. Since restriction was similar in different individuals, it is likely that it is a general attribute of the light chain repertoire. Indeed, Ignatovic et al (20) and Farner et al (21) , who have published the only two studies on the topic, documented similar restrictions in the expression repertoires of peripheral blood lymphocytes from individual donors. With few exceptions, the bias was found essentially for the pool of germline genes we identified. However, the extent of use of single V segments was rather different. In both studies, there was lower expression of the III family [11 to 20% (20) ; 16% (21) Inverse PCR allowed unequivocal identification of monoclonal light chains from all 55 amyloid bone marrows. In line with the post-germinal center origin of amyloid plasma cells, there was no significant intraclonal nucleotide substitution, confirming our previous report (12) . We found that the V expression repertoire in AL was characterized by marked overrepresentation of two genes, namely 3r and 6a. Together these genes accounted for up to 42% of amyloid light chains. The preferential association of VI (6a) light chains with amyloidosis is well established since the pioneering studies of Solomon et al (6) in the early 1980s. Subsequent work using protein sequencing unequivocally demonstrated that virtually all VI monoclonal light chains isolated so
are from amyloidosis patients. By means of ELISA typing with monoclonal antibodies to the various families, Solomon and colleagues (7) established that the prevalence of VI light chains in amyloidosis could reach 30%, whereas VI light chains are barely found in normal serum (5%).
Our report is in line with the results of these studies and confirms the rarity of polyclonal plasma cells expressing VI light chains (2.3%).
Our previous sequencing work on somatic mutations in amyloid light chains showed that 4 of 9 light chains used the 3r gene, suggesting that this segment might be frequently rearranged in this condition (12) . Before our present study, information on the rearrangement rate of 3r in the expression repertoire was limited to the above-cited analysis on normal peripheral blood B cells, studies that identified 3r only at low frequencies (3% and 7%) (20, 21) . We now establish that the prevalence of 3r-light chains in amyloidosis (22%) is three times higher than in polyclonal marrow plasma cells (8.3%), thus identifying a new amyloid-associated V gene (P=.024). The present sequencing data suggest that bias in 3r-usage may be typical of amyloidosis, possibly related to its amyloidogenic potential, rather than a general feature of plasma cell dyscrasias. A recent exhaustive revision of nucleotide sequencing data in myeloma and related conditions found no evidence of bias in V use (27) , while we observed 3r rearranged only twice in a total of 27 myeloma V regions it is possible that the few amino acid differences between J 1 and J 2/3 play a role in determining the amyloidogenicity of certain 3r-light chains.
Somatic mutations were found in all sequence, and the overall frequency of mutations was lower in amyloid than in polyclonality. This phenomenon could be partly attributed to the high prevalence of VI light chains in amyloid, the family that was more homologous to germline compared to the most common one, the III. Of interest, amyloid 6a-light chains were less mutated than their 3r-counterparts too. High mutation rates indicate prolonged permanence or repeated selection circuits through the germinal center, a feature that may be typical of clones with frequently used light chains, such as those with III light chains.
A secondary aim of the study was to determine whether germline gene use might relate to the different organ tropism that is typical of primary amyloidosis. To this same end, Comenzo et al (8) very recently reported the sequencing results from 60 patients with amyloidosis (48 of the type).
The authors (8) were able to establish an association between 6a-light chains and major or exclusive amyloid kidney involvement, an association that was further substantiated by amyloid formation from VI light chains cultured in a human mesangial cell model. In the present study, we confirmed this seminal observation (8): 8 of 11 VI light chains (P=.019) were isolated from patients with predominant kidney involvement at diagnosis. On the other hand, the present analysis does not allow identification of other germline genes with such a direct relationship to organ damage: 3r-light chains seem to be capable of infiltrating various targets, with a distribution that apparently parallels that in the general amyloid population (Figure 6 ). Given the dispersion of data (multiple organ involvement and various gene usage), further gene usage analyses will be needed to address this matter of great biological and clinical relevance more fully.
In conclusion, this study reports the first comparative V gene usage analysis in amyloid and polyclonal marrow plasma cells. It demonstrates that a relevant proportion of amyloidogenic and polyclonal light chains are synthesized through recombination of just a few gene segments. Such a restriction is particularly evident in amyloidosis in which two gene segments, namely 3r and 6a, are preferentially expressed. Since these segments are responsible for approximately 40% of total amyloid light chains, overrepresentation of 3r and 6a can account for the light chain predominance typical of AL amyloidosis. In addition, while 3r-patients apparently present amyloid
For personal use only. on October 19, 2017 . by guest www.bloodjournal.org From infiltration of various organs, this study confirms the previous observation that 6a-light chains preferentially generate amyloid in the kidney (8) . These findings may have relevance for a better comprehension of the mechanisms underlying amyloidogenicity of light chains. The fact that just two genes are highly overrepresented in amyloidosis will help in designing DNA-based vaccine approaches as well as molecules capable of interfering with the amyloid deposition process. 
